Bridger Management is an investment fund managing more than $194 billion ran by Matthew Truax. There are currently 27 companies in Mr. Truax’s portfolio. The largest investments include Eli Lilly Co and Uber Technologies Inc, together worth $44.3 billion.
As of 7th August 2024, Bridger Management’s top holding is 24,712 shares of Eli Lilly Co currently worth over $22.4 billion and making up 11.5% of the portfolio value.
In addition, the fund holds 301,457 shares of Uber Technologies Inc worth $21.9 billion, whose value fell 10.2% in the past six months.
The third-largest holding is Vertex Pharmaceuticals worth $19.2 billion and the next is Morgan Stanley worth $18.2 billion, with 187,714 shares owned.
Currently, Bridger Management's portfolio is worth at least $194 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Bridger Management office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, Matthew Truax serves as the COO, GC & CCO at Bridger Management.
In the most recent 13F filing, Bridger Management revealed that it had opened a new position in Eli Lilly Co and bought 24,712 shares worth $22.4 billion.
The two most similar investment funds to Bridger Management are Flynn Zito Capital Management and Chelsea Counsel Co. They manage $194 billion and $194 billion respectively.
Bridger Management’s portfolio is diversified across 6 sectors.
Currently, their heaviest sector is Health Care — making up 33.2% of
the total portfolio value.
The fund focuses on investments in the United States as
59.3% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
30% of the total holdings value.
On the other hand, small-cap stocks make up only 3.7% of the portfolio.
The average market cap of the portfolio companies is close to $214 billion.
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
Security | Shares Owned | Value | Allocation |
---|---|---|---|
Eli Lilly Co |
Opened
24,712
|
$22,373,751,000 | 11.51% |
Uber Technologies Inc |
Opened
301,457
|
$21,909,895,000 | 11.27% |
Vertex Pharmaceuticals, Inc. |
Opened
41,050
|
$19,240,956,000 | 9.90% |
Morgan Stanley |
Opened
187,714
|
$18,243,924,000 | 9.39% |
Teva Pharmaceutical Inds Ltd |
Opened
981,000
|
$15,941,250,000 | 8.20% |
Pfizer Inc. |
Opened
350,500
|
$9,806,990,000 | 5.05% |
Taiwan Semiconductor Mfg Ltd |
Opened
51,826
|
$9,007,877,000 | 4.64% |
Alnylam Pharmaceuticals Inc |
Opened
37,022
|
$8,996,346,000 | 4.63% |
Bath Body Works Inc |
Opened
221,902
|
$8,665,273,000 | 4.46% |
Bausch Plus Lomb Corp |
Opened
506,343
|
$7,352,100,000 | 3.78% |
Melco Resorts And Entmnt Ltd |
Opened
983,694
|
$7,338,357,000 | 3.78% |
Caesars Entertainment Inc Ne |
Opened
147,625
|
$5,866,618,000 | 3.02% |
Xenon Pharmaceuticals Inc |
Opened
146,800
|
$5,723,732,000 | 2.95% |
Geron Corp. |
Opened
1,338,084
|
$5,673,476,000 | 2.92% |
SpringWorks Therapeutics, Inc. |
Opened
144,526
|
$5,444,294,000 | 2.80% |
Dexcom Inc |
Opened
28,900
|
$3,276,682,000 | 1.69% |
Catalyst Pharmaceuticals Inc |
Opened
184,527
|
$2,858,323,000 | 1.47% |
Alphabet Inc |
Opened
13,900
|
$2,531,885,000 | 1.30% |
Quanterix Corp |
Opened
154,900
|
$2,046,229,000 | 1.05% |
Hillevax Inc |
Opened
140,100
|
$2,025,846,000 | 1.04% |
Microsoft Corporation |
Opened
4,230
|
$1,890,599,000 | 0.97% |
Terns Pharmaceuticals Inc |
Opened
246,800
|
$1,680,708,000 | 0.86% |
Uniqure Nv |
Opened
362,349
|
$1,623,324,000 | 0.84% |
Oscar Health, Inc. |
Opened
95,700
|
$1,513,974,000 | 0.78% |
Amazon.com Inc. |
Opened
7,264
|
$1,403,768,000 | 0.72% |
Toast, Inc. |
No change
52,692
|
$1,357,873,000 | 0.70% |
NextDecade Corporation |
No change
67,837
|
$538,626,000 | 0.28% |
No transactions found | |||
Showing first 500 out of 27 holdings |